A graduate of McGill University, Montreal, Pamela Ann Weber, M.D. went to Columbia University College of Physicians & Surgeons. Dr. Weber completed her Post-Doctoral training as a Resident in Ophthalmology at New York Eye and Ear Infirmary, NY. She completed her Fellowship in Vitreoretinal Disease & Surgery at Schepens Eye Institute, Mass Eye and Ear Infirmary, and Harvard University in Boston. Dr. Weber is a member of National Register’s Who’s Who, a Castle Connolly Top Doctor and a Newsday Top Doctor.
A graduate of McGill University, Montreal, Pamela Ann Weber, M.D. went to Columbia University College of Physicians & Surgeons. Dr. Weber completed her Post-Doctoral training as a Resident in Ophthalmology at New York Eye and Ear Infirmary, NY. She completed her Fellowship in Vitreoretinal Disease & Surgery at Schepens Eye Institute, Mass Eye and Ear Infirmary, and Harvard University in Boston. Dr. Weber is a member of National Register’s Who’s Who, a Castle Connolly Top Doctor and a Newsday Top Doctor.
A graduate of McGill University, Montreal, Pamela Ann Weber, M.D. went on to Columbia University College of Physicians & Surgeons. Dr. Weber completed her Post-Doctoral training as a Resident in Ophthalmology at the New York Eye and Ear Infirmary, NY. She completed her Fellowship in Vitreoretinal Disease & Surgery at Schepens Eye Institute, Mass Eye and Ear Infirmary, and Harvard University in Boston. Dr. Weber is a member of the National Register’s Who’s Who, a Castle Connolly Top Doctor and a Newsday Top Doctor. Dr. Pamela Weber is certified by the American Board of Ophthalmology. She is also a member of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, and the American Association of Retinal Specialists.
Dr. Weber has additionally been involved in international studies for diabetes, AIDS and macular degeneration. She has traveled the country giving lectures for Genentech. She has also lectured internationally for Pfizer.
Dr. Weber has a special interest in retinopathy of prematurity and has participated in National Eye Institute funded multicenter studies including ETROP (Early Treatment of Retinopathy) and STOP-ROP (Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity). She served on the Executive Committee and the Outcomes Committee for STOP-ROP.
wonderful doctor and team. I felt very comfortable with them.
Great staff and Doctor
Excellent care from start to finish wonderful helpers And Dr. Weber was very thorough, and very nice❣️
Excellent service and expertise
She is simply the best!!!!
Excellent care. Wonderful office staff.
Typical experience
Dr Weber was both professional and compassionate. Her staff was excellent, from the minute we walked in until we left. This office was a great experience.
Complete professional. We have recommended her to several people. She is an outstanding doctor and person
Very friendly and professional staff. Dr. Weber is an exceptional doctor. I would recommend Dr Weber to any person I know that needs to see a retinal doctor.